Sichenzia Ross Friedman Ference LLP Advises Conkwest, Inc. on $7.06 million Private Placement of Units consisting of Series C Convertible Preferred Stock and Warrants to Purchase Common Stock.
NEW YORK, April 11, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Conkwest, Inc. in a $7.06 million private placement of the Preferred Stock and Warrants of Conkwest, Inc., a privately held company which is involved in the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer killing cell-lines. The private placement was pursuant to Rule 506 of Regulation D. The offering consisted of 2,943,698 Units consisting of 2,943,698 shares of Series C Preferred Stock and 735,924 warrants to purchase common stock shares at $2.40 per Unit for a total offering of $7,064,875. Palladium Capital Corp. acted as placement agent on the offering. The Sichenzia Ross Friedman Ference LLP teamwas led by partners Harvey Kesner and Arthur S. Marcus.
Media Contact:
pr@srf.law
212-930-9700
- Sichenzia Ross Ference Carmel LLP 代表 WallachBeth Capital LLC 和 Revere Securities LLC 参与 Trident Digital Tech Holdings Ltd 的 900 万美元首次公开发行。 - September 11, 2024
- Sichenzia Ross Ference Carmel LLP 代表 EF Hutton 参与 Solidion Technology, Inc. 400 万美元的私募交易。 - September 9, 2024
- Sichenzia Ross Ference Carmel LLP 代表 Joseph Gunnar & Co, LLC 参与 Eastside Distilling 的 40 万美元注册直接发行 - September 6, 2024